My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 221

    1.

    Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000.

    Icks A, Haastert B, Gandjour A, John J, Löwel H, Holle R, Giani G, Rathmann W; KORA Study Group.

    Diabetes Care. 2004 Sep;27(9):2120-8.PMID: 15333472 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies.

    Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM.

    Diabetes Care. 2003 Sep;26(9):2536-42.PMID: 12941715 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.

    Icks A, Rathmann W, Haastert B, Gandjour A, Holle R, John J, Giani G; KORA Study Group.

    Diabet Med. 2007 May;24(5):473-80. Epub 2007 Mar 22.PMID: 17381502 [PubMed - indexed for MEDLINE]Related articles

    4.

    Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.

    Wang W, Lee ET, Fabsitz R, Welty TK, Howard BV.

    Diabetes Care. 2002 Aug;25(8):1365-70.PMID: 12145236 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cost-effectiveness of type 2 diabetes screening: results from recently published studies.

    Icks A, Rathmann W, Haastert B, John J, Löwel H, Holle R, Giani G; KORA Study Group.

    Gesundheitswesen. 2005 Aug;67 Suppl 1:S167-71.PMID: 16032536 [PubMed - indexed for MEDLINE]Related articles

    7.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.

    Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J; AusDiab.

    Diabetes Care. 2004 Feb;27(2):367-71.PMID: 14747215 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

    Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A.

    Diabetes Care. 2005 May;28(5):1187-94.PMID: 15855587 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.

    Adam JM, Tarigan NP.

    Acta Med Indones. 2004 Jan-Mar;36(1):3-7.PMID: 15931695 [PubMed - indexed for MEDLINE]Related articles

    11.

    Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.

    Kim C, Herman WH, Vijan S.

    Diabetes Care. 2007 May;30(5):1102-6. Epub 2007 Feb 23.PMID: 17322480 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.

    [No authors listed]

    JAMA. 1998 Nov 25;280(20):1757-63. Erratum in: JAMA 1999 Jan 27;281(4):325. PMID: 9842951 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

    Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K.

    BMJ. 2008 May 24;336(7654):1180-5. Epub 2008 Apr 21.PMID: 18426840 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?

    Sargeant LA, Boyne MS, Bennett FI, Forrester TE, Cooper RS, Wilks RJ.

    Rev Panam Salud Publica. 2004 Jul;16(1):35-42.PMID: 15333264 [PubMed - indexed for MEDLINE]Related articles

    15.

    Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.

    Tanaka Y, Atsumi Y, Matsuoka K, Mokubo A, Asahina T, Hosokawa K, Shimada S, Matsunaga H, Takagi M, Ogawa O, Onuma T, Kawamori R.

    Diabetes Res Clin Pract. 2001 Jul;53(1):41-5.PMID: 11378212 [PubMed - indexed for MEDLINE]Related articles

    16.

    Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?

    Bur A, Herkner H, Woisetschläger C, Vlcek M, Derhaschnig U, Hirschl MM.

    Am J Hypertens. 2003 Apr;16(4):297-301.PMID: 12670746 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities]

    Gołembiewska E.

    Ann Acad Med Stetin. 2004;50(1):131-8. Polish. PMID: 16871752 [PubMed - indexed for MEDLINE]Related articles

    18.

    HbA1c screening for undiagnosed diabetes in New Zealand.

    Ellison TL, Elliott R, Moyes SA.

    Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):65-70.PMID: 15386815 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests.

    Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B.

    Diabetes Care. 2006 Feb;29(2):363-7.PMID: 16443888 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis.

    Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G.

    Diabetes Care. 1999 Sep;22(9):1490-3.PMID: 10480514 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity